NASDAQ NMS - GLOBAL MARKET · KYNB
+2.85% · +$0.1700 · Vol 16.8K
After hours · updated 16:00:00 ET
Kyntra Bio Inc

Kyntra Bio Inc

Biotechnology
$6.13
Card
Relationship Map

Follow $KYNB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $KYNB by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
KYNB
Kyntra Bio Inc
Wed Oct 7 · session closed · Markets closed · resumes Thu 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Wed Oct 7 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KYNB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KYNB catalysts
About Kyntra Bio Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
34
Country
US

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.85
Day high
$6.35
Day low
$5.85
Previous close
$5.96
52W high
$9.50
-35.47% from high
52W low
$5.85
8% of range
Market cap
$24.1M
P/E
0.13×
EPS
$45.30
Beta
0.07
Shares out
4M
Volume
16.8K
0.66× rel vol
Avg volume
25.6K
VWAP
$6.15
Price history computed in-house
1W
-7.82%
1M
-28.30%
3M
-16.26%
SMA 50 $7.29 · below
SMA 200 Not reported · Not reported
52W position 8%

KYNB overview

Veridion Score
54
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KYNB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KYNB Form 4 filings
Public disclosures

Congress activity in KYNB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

KYNB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KYNB in this window.
Lobbying spend

KYNB lobbying filings, year to date.

Registered lobbying filings matched to Kyntra Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KYNB in this window.
Loading news for KYNB
Analyst ratings
Sovereign unlock shows live analyst consensus for KYNB.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.